keyword
https://read.qxmd.com/read/38614283/postoperative-radiotherapy-results-in-192-epithelial-thymic-tumours-patients-with-10%C3%A2-years-of-follow-up
#1
JOURNAL ARTICLE
Hugo Lopez, Angela Botticella, Farid Belkhir, Benjamin Besse, Elie Fadel, Olaf Mercier, Antonin Levy, Cécile Le Péchoux
PURPOSE: To assess the prognostic factors and patterns of failure of patients consecutively treated with surgery and postoperative radiation therapy (PORT) for thymic epithelial tumours (TET). PATIENTS AND METHODS: Data from 192 TET patients who were operated and received PORT at a single centre from 1990 to 2019 was retrospectively analysed. RESULTS: Most patients had thymoma (77 %, B247%), were classified Masaoka-Koga stage III (35 %) or IV (32 %) and had a R0 (75 %) resection...
April 11, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/38600335/the-role-of-calcification-in-predicting-invasion-of-thymoma-to-adjacent-organs
#2
JOURNAL ARTICLE
Miyashita Yudai, Kanou Takashi, Ishida Hiroto, Fukui Eriko, Kimura Toru, Ose Naoko, Funaki Soichiro, Shintani Yasushi
PURPOSE: Thoracoscopic procedures such as video-assisted thoracoscopic surgery (VATS) and robot-assisted thoracoscopic surgery (RATS) have gained popularity for the treatment of thymoma. Accurate preoperative assessments of tumor invasion are crucial to identifying the appropriate surgical approach. Although imaging techniques have been used to predict invasion, a quantifiable method is still needed in clinical practice. METHODS: The ubjects of this retrospective study were 226 patients with thymoma who underwent surgery at our hospital...
April 11, 2024: Surgery Today
https://read.qxmd.com/read/38596135/clinical-characteristics-of-late-onset-myasthenia-gravis
#3
JOURNAL ARTICLE
Chenjing Sun, Zhuangzhuang Ren, Xiuling Miao, Yanxu Zheng, Jun Zhang, Xiaokun Qi, Jianguo Liu, Feng Qiu
OBJECTIVE: Late-onset myasthenia gravis (LOMG) often has comorbidities, and its initial symptoms may be ignored or misdiagnosed as other diseases. There were few large surveys on LOMG. Our study aimed to summarize clinical characteristics of LOMG to improve the rate of correct MG diagnosis. METHODS: A retrospective cohort study included 240 LOMG patients with onset age ≥65 years old who were treated at PLA General Hospital from January 1, 2003 to January 1, 2023...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38398164/therapeutic-decision-making-in-prevascular-mediastinal-tumors-using-ct-radiomics-and-clinical-features-upfront-surgery-or-pretreatment-needle-biopsy
#4
JOURNAL ARTICLE
Chao-Chun Chang, Chia-Ying Lin, Yi-Sheng Liu, Ying-Yuan Chen, Wei-Li Huang, Wu-Wei Lai, Yi-Ting Yen, Mi-Chia Ma, Yau-Lin Tseng
The study aimed to develop machine learning (ML) classification models for differentiating patients who needed direct surgery from patients who needed core needle biopsy among patients with prevascular mediastinal tumor (PMT). Patients with PMT who received a contrast-enhanced computed tomography (CECT) scan and initial management for PMT between January 2010 and December 2020 were included in this retrospective study. Fourteen ML algorithms were used to construct candidate classification models via the voting ensemble approach, based on preoperative clinical data and radiomic features extracted from the CECT...
February 13, 2024: Cancers
https://read.qxmd.com/read/38345885/the-impact-of-thymectomy-in-thymomatous-and-nonthymomatous-myasthenia-gravis-the-experience-of-a-tertiary-center
#5
JOURNAL ARTICLE
Sara Cunha, Pedro Faustino, André Jorge, Luís L Graça, Luciano Almendra, Anabela Matos, Luís Negrão, Rita Pancas
INTRODUCTION: Thymectomy remains a mainstay of treatment in Thymomatous (T) and Nonthymomatous (nT) Myasthenia Gravis (MG), with improved clinical outcomes and reduced need for medical treatment, however, there is little research regarding long-term follow-up. We aim to assess the impact of surgery on the long-term outcome of patients with MG at our center. METHODS: Retrospective analyses of MG patients submitted to thymectomy between 2007 and 2017 at the thoracic surgery department of CHUC...
February 9, 2024: Port J Card Thorac Vasc Surg
https://read.qxmd.com/read/38338833/the-molecular-landscape-of-thymic-epithelial-tumors-a-comprehensive-review
#6
REVIEW
Lisa Elm, Georgia Levidou
Thymic epithelial tumors (TETs) are characterized by their extreme rarity and variable clinical presentation, with the inadequacy of the use of histological classification alone to distinguish biologically indolent from aggressive cases. The utilization of Next Generation Sequencing (NGS) to unravel the intricate genetic landscape of TETs could offer us a comprehensive understanding that is crucial for precise diagnoses, prognoses, and potential therapeutic strategies. Despite the low tumor mutational burden of TETS, NGS allows for exploration of specific genetic signatures contributing to TET onset and progression...
January 26, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38306885/international-reproducibility-study-of-thymic-epithelial-tumors-staging-pt-stage-is-an-issue-proposals-for-improvement-a-rythmic-itmig-study
#7
JOURNAL ARTICLE
Thierry J Molina, Anja C Roden, Malgorzata Szolkowska, Shigeki Shimizu, Andre L Moreira, Lara Chalabreysse, Benjamin Besse, Vincent de Montpréville, Edith M Marom, Frank Detterbeck, Nicolas Girard, Andrew G Nicholson, Alexander Marx
INTRODUCTION: Pathologists are staging thymic epithelial tumors (TET) according to the 8th UICC/AJCC TNM system. Within the French RYTHMIC network, dedicated to TET, agreement on pathologic tumor stage (pT) among the pathology panelists was difficult. The aim of our study was to determine the interobserver reproducibility of pT at an international level, to explore the source of discrepancies and potential interventions to address these. METHODS: An international panel of pathologists was recruited through the International Thymic Malignancy Interest Group (ITMIG)...
January 24, 2024: Lung Cancer: Journal of the International Association for the Study of Lung Cancer
https://read.qxmd.com/read/38276116/tnm-staging-system-in-thymoma-a-critical-appraisal
#8
REVIEW
Marcello Carlo Ambrogi, Vittorio Aprile, Alessandra Lenzini, Diana Bacchin, Maria Giovanna Mastromarino, Stylianos Korasidis, Marco Lucchi
Thymomas are rare tumors of the anterior mediastinum with peculiar clinical and pathological features. They have been deeply analyzed by pioneer authors, who strictly linked their name to the main pathological and staging classifications. Before the latest edition of the WHO classification of thymic epithelial tumors, the history of thymoma pathological classification inherited the name of the pathologists who systematically addressed the issue, from Levine-Rosai to Muller-Hermelink. Similarly, the thymoma staging system is intimately related to the name of two surgeons, Masaoka and Koga, who historically dealt with this disease...
January 21, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38199878/mark-wick-contributions-to-pathology-of-the-mediastinum
#9
REVIEW
Horacio Maluf
Mark Wick made a wide range of contributions to the field of mediastinal pathology. Early papers amplified the spectrum of neuroendocrine carcinomas of the thymus and brought attention to the aggressive nature of this tumor, also highlighting the occurrence of coexisting carcinoid tumor and small cell carcinoma of this organ. The controversial issue of thymoma classification was addressed in several papers and editorial comments, while also reporting a case of metastatic thymoma. A series of thymic carcinomas as well a report on the unusual clear cell variant bear his name as one of the authors...
January 7, 2024: Seminars in Diagnostic Pathology
https://read.qxmd.com/read/38165166/evaluation-of-the-effect-of-pet-ct-fluorodeoxyglucose-inclusion-on-mortality-and-survival-in-operated-thymoma-patients
#10
JOURNAL ARTICLE
Bahar Agaoglu Sanli, Elif Duman, Bariş Gulmez, Nurşin Aguloglu, Serkan Yazgan, Kenan Can Ceylan, Ahmet Ucvet
PURPOSE: In recent years, the use of fluorodeoxyglucose PET-computed tomography (PET-CT) has become widespread to evaluate the diagnosis, metabolism, stage and distant metastases of thymoma. In this study, it was aimed to investigate the connection of malignancy potential, survival and maximum standardized uptake value (SUVmax) measured by PET-CT before surgery according to the histological classification of the WHO in patients operated for thymoma. In addition, the predictive value of the Glasgow prognostic score (GPS) generated by C-reactive protein (CRP) and albumin values on recurrence and survival was investigated and its potential as a prognostic biomarker was evaluated...
December 28, 2023: Nuclear Medicine Communications
https://read.qxmd.com/read/38159470/macrophage-migration-inhibitory-factor-a-noval-biomarker-upregulates-in-myasthenia-gravis-and-correlates-with-disease-severity-and-relapse
#11
JOURNAL ARTICLE
Xiaoyu Huang, Hao Li, Zhouao Zhang, Zhouyi Wang, Xue Du, Yong Zhang
OBJECTIVE: To explore the relationship between macrophage migration inhibitory factor (MIF) and disease severity and relapse in patients with myasthenia gravis (MG). METHODS: 145 MG patients including 79 new-onset patients, 30 remission patients and 36 relapse patients were enrolled in this study. The detailed characteristics of all enrolled MG patients were routinely recorded, including gender, age, type, MGFA classification, antibody, thymic status, clinical score, treatment, MGFA-PIS and B cell subsets (memory B cells, plasmablast cells and plasma cells) detected by flow cytometry...
December 29, 2023: Cytokine
https://read.qxmd.com/read/38152089/guideline-for-the-management-of-myasthenic-syndromes
#12
REVIEW
Heinz Wiendl, Angela Abicht, Andrew Chan, Adela Della Marina, Tim Hagenacker, Khosro Hekmat, Sarah Hoffmann, Hans-Stefan Hoffmann, Sebastian Jander, Christian Keller, Alexander Marx, Arthur Melms, Nico Melzer, Wolfgang Müller-Felber, Marc Pawlitzki, Jens-Carsten Rückert, Christiane Schneider-Gold, Benedikt Schoser, Bettina Schreiner, Michael Schroeter, Bettina Schubert, Jörn-Peter Sieb, Fritz Zimprich, Andreas Meisel
Myasthenia gravis (MG), Lambert-Eaton myasthenic syndrome (LEMS), and congenital myasthenic syndromes (CMS) represent an etiologically heterogeneous group of (very) rare chronic diseases. MG and LEMS have an autoimmune-mediated etiology, while CMS are genetic disorders. A (strain dependent) muscle weakness due to neuromuscular transmission disorder is a common feature. Generalized MG requires increasingly differentiated therapeutic strategies that consider the enormous therapeutic developments of recent years...
2023: Therapeutic Advances in Neurological Disorders
https://read.qxmd.com/read/38150890/rs1800629-polymorphism-in-tnf-alpha-is-associated-with-the-susceptibility-and-initial-short-term-glucocorticoids-efficacy-in-myasthenia-gravis-patients
#13
JOURNAL ARTICLE
Hong-Yan Li, Meng Xia, Min Song, Yanchen Xie, Qi Wang, Yao-Xian Yue, Hai-Feng Li
Tumor necrosis factor-alpha (TNF-α) is a potent pro-inflammatory agent involved in various autoimmune and inflammatory diseases including myasthenia gravis (MG). In this study, we enrolled 409 adult MG patients and 487 healthy individuals to investigate the association between TNF-α polymorphism and MG. We found the rs1800629 A allele frequency was significantly higher in the MG group than in the control group. Subgroup analysis revealed that the A allele frequencies were significantly higher in the early-onset subgroup, non-thymoma subgroup, ocular-onset subgroup, and mild severity subgroup than in the control group...
December 20, 2023: Journal of Neuroimmunology
https://read.qxmd.com/read/38090038/pathological-snapshots-of-thymic-epithelial-tumors-with-invasion-into-neighboring-structures-preparing-for-the-forthcoming-revision-of-the-tnm-classification
#14
REVIEW
Yosuke Yamada, Hironori Haga
Treatment decision-making of thymic epithelial tumors (TETs) after surgery is based on the pathological stage. Currently, most institutions use both the Masaoka-Koga system and the 8th edition of the tumor, node, metastasis (TNM) classification. Because these two systems separate each stage according to the same concept, namely, the "levels" of tumor extension, precise pathological evaluation of the presence or absence of tumor invasion into stage-defining structures is necessary. This review provides representative pathological snapshots of tumors invading neighboring structures to provide references that might be helpful to readers; the snapshots will cover features that correspond to those of "locally advanced TETs", the topic of this series...
2023: Mediastinum
https://read.qxmd.com/read/38090032/histopathological-features-of-giant-mediastinal-tumors-a-literature-review
#15
REVIEW
Luka Brcic, Anja C Roden
BACKGROUND AND OBJECTIVE: Mediastinal lesions are uncommon. However, because of the vital structures in the mediastinum, large lesions specifically can lead to life-threatening situations. Treatment and management vary considerably with the disease. Therefore, the correct histopathologic diagnosis is important. Here we review lesions that have the potential to present as a giant lesion in the mediastinum. While we focus on the review of histopathologic, immunohistochemical (IHC), and molecular features of these lesions, clinical symptoms and characteristics and prognosis will also be discussed...
2023: Mediastinum
https://read.qxmd.com/read/38058787/clinicodemographic-characteristics-and-prognostic-role-of-myasthenia-gravis-in-thymoma-experience-from-a-saudi-population
#16
JOURNAL ARTICLE
Abdullah Al Shammari, Aida Saad, Lama Tareq Saif, Safy A Othman, Mohammad J Ghosheh, Ghadir M Khdeir, Omniyah Alashgar, Mohammed A Abu-Rayya, Mohamed Hussein Ahmed, Khaled AlKattan, Waleed Saleh
OBJECTIVES: The objectives of the study were to determine the clinicodemographic characteristics and the prognostic role of myasthenia gravis (MG) in thymoma. METHODS: The records of patients who underwent surgical resection of thymoma at King Faisal Specialist Hospital and Research Center in the past 23 years were reviewed. Seventy thymoma patients were finally included and were then categorized based on MG status into the MG group (39 patients) and the non-MG group (31 patients)...
2023: Annals of Thoracic Medicine
https://read.qxmd.com/read/38035080/in-depth-blood-immune-profiling-of-good-syndrome-patients
#17
JOURNAL ARTICLE
Alba Torres-Valle, Larraitz Aragon, Susana L Silva, Cristina Serrano, Miguel Marcos, Josefa Melero, Carolien Bonroy, Pedro Pablo Arenas-Caro, David Monzon Casado, Pedro Mikel Requejo Olaizola, Jana Neirinck, Mattias Hofmans, Sonia de Arriba, María Jara, Carlos Prieto, Ana E Sousa, Álvaro Prada, Jacques J M van Dongen, Martín Pérez-Andrés, Alberto Orfao
INTRODUCTION: Good syndrome (GS) is a rare adult-onset immunodeficiency first described in 1954. It is characterized by the coexistence of a thymoma and hypogammaglobulinemia, associated with an increased susceptibility to infections and autoimmunity. The classification and management of GS has been long hampered by the lack of data about the underlying immune alterations, a controversy existing on whether it is a unique diagnostic entity vs . a subtype of Common Variable Immune Deficiency (CVID)...
2023: Frontiers in Immunology
https://read.qxmd.com/read/37998604/unsolved-issues-in-thymic-epithelial-tumour-stage-classification-the-role-of-tumour-dimension
#18
JOURNAL ARTICLE
Carolina Sassorossi, Pietro Bertoglio, Filippo Lococo, Gloria Santoro, Elisa Meacci, Dania Nachira, Maria Teresa Congedo, Jury Brandolini, Matteo Petroncini, Adriana Nocera, Diepriye Charles-Davies, Piergiorgio Solli, Stefano Margaritora, Marco Chiappetta
According to the different classifications now in use, thymic tumours are staged by the extent of local invasiveness, and tumour size is not included as a major determinant for the T category. The aim of this double-site retrospective study is to analyse the correlation between tumour dimension and overall survival (OS) in patients who underwent surgical treatment. From January 2000 to December 2020, patients with thymic epithelial tumours who underwent surgical resection were included in this study. Data from a total of 332 patients were analysed...
November 17, 2023: Diagnostics
https://read.qxmd.com/read/37994555/thymic-epithelial-tumours-histopathological-classification-and-differential-diagnosis
#19
REVIEW
Jan von der Thüsen
The epithelial and lymphoid compartments of the thymus can give rise to a wide variety of tumours, including thymomas, thymic carcinomas, lymphoreticular proliferations, germ cell tumours, and sarcomas. While some of these have close similarity to their counterparts in other organs, both in terms of histology and immunohistochemistry, as well as molecular features, others are unique to the thymus. The epithelial tumours, which can develop in the thymus, will be discussed in this review, with a particular emphasis on resolving differential diagnosis by means of morphology, immunohistochemical profiles, and molecular diagnostics...
January 2024: Histopathology
https://read.qxmd.com/read/37897424/ectopic-cervical-thymoma-in-a-patient-diagnosed-with-graves-disease-a-systematic-literature-review
#20
JOURNAL ARTICLE
Samuel Nemiroff, Raymond Chai, Jun Fan, Ilana Ramer-Bass
Thymomas are benign thymic epithelial neoplasms, rarely found outside the anterior mediastinum. Although hyperthyroid states have been associated with thymic hyperplasia, only 3 thymoma cases have been previously reported in patients with Graves Disease (GD), all within the anterior mediastinum. Here, we report a case of ectopic cervical thymoma in a 22-year-old female patient previously treated for GD. The patient underwent ultrasonography, computed tomography, inconclusive fine-needle aspiration, and ultimately gross dissection for diagnostic workup and definitive treatment of an anterior neck mass, producing a 2...
October 28, 2023: Journal of Clinical Endocrinology and Metabolism
keyword
keyword
164694
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.